Karmanos Center Institute — Detroit, Michigan

Karmanos Center Institute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Center Institute has participated in 1 clinical trials.

Therapeutic areas: ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Center Institute?

Karmanos Center Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Center Institute conducted?

Karmanos Center Institute has 1 clinical trials on record. Their work covers ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC.

Is Karmanos Center Institute accredited by Crixeo Health?

Karmanos Center Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Center Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.